Section Arrow
Quote
ZYBT.NASDAQ
- Zhengye Biotechnology Holding Limited
Quotes are at least 15-min delayed:2025/07/19 03:38 EDT
Regular Hours
Last
 5.69
-0.18 (-3.07%)
Day High 
5.8785 
Prev. Close
5.87 
1-M High
9.69 
Volume 
19.41K 
Bid
5.65
Ask
5.8
Day Low
5.665 
Open
5.71 
1-M Low
5.17 
Market Cap 
278.19M 
Currency USD 
P/E 161.94 
%Yield -- 
10-SMA 5.9 
20-SMA 6.55 
50-SMA 7.62 
52-W High 14.3 
52-W Low 3.5 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.24/--
Enterprise Value
282.99M
Balance Sheet
Book Value Per Share
0.84
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
186.36M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IXHLIncannex Healthcare0.61+0.2399+64.82%-- 
TLRYTilray Brands0.6213+0.01+1.64%-- 
TEVATeva Pharmaceutical Industries Limited16.06-0.25-1.53%-- 
VTRSViatris8.88-0.39-4.21%227.2PE
HLNHaleon plc9.6+0.01+0.10%22.76PE
Quotes are at least 15-min delayed：2025/07/19 03:38 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry, and other vaccines.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.